Profile
Arnaud Foussat was the founder of Alderaan Biotechnology SAS, founded in 2017, where the title held was Chief Executive Officer from 2017 to 2024.
The current job is Chairman at Yukin Therapeutics SAS, starting in 2019.
Former jobs include Principal at Institut National de la Santé & de la Recherche Médicale, and Chief Scientific Officer & Vice President at Sangamo Therapeutics France SAS from 2015 to 2017.
Education includes undergraduate studies at the University of Strasbourg and a doctorate from Université Paris Diderot-Paris 7.
Arnaud Foussat active positions
| Companies | Position | Start |
|---|---|---|
Yukin Therapeutics SAS
Yukin Therapeutics SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Chief Executive Officer | 01/06/2018 |
Former positions of Arnaud Foussat
| Companies | Position | End |
|---|---|---|
Alderaan Biotechnology SAS
Alderaan Biotechnology SAS BiotechnologyHealth Technology Operates as preclinical stage company for monoclonal antibodies development for the treatment of cancer | Chief Executive Officer | 01/03/2024 |
| TXCELL | Chief Tech/Sci/R&D Officer | 01/03/2017 |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Corporate Officer/Principal | - |
Training of Arnaud Foussat
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Research institute | Commercial Services |
University of Strasbourg
University of Strasbourg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris Diderot-Paris 7
Université Paris Diderot-Paris 7 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sangamo Therapeutics France SAS
Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases | Health Technology |
Yukin Therapeutics SAS
Yukin Therapeutics SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparations | Health Technology |
Alderaan Biotechnology SAS
Alderaan Biotechnology SAS BiotechnologyHealth Technology Operates as preclinical stage company for monoclonal antibodies development for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Arnaud Foussat
















